HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

LX0702

a platelet aggregation inhibitor; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Sulfonamides: 2809
    - LX0702: 1
- Sulfur Compounds: 278
  - Sulfones: 534
    - Sulfonamides: 2809
      - LX0702: 1
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Essential Amino Acids: 1152
    - Tryptophan: 6733
      - LX0702: 1
  - Cyclic Amino Acids: 3
    - Aromatic Amino Acids: 467
      - Tryptophan: 6733
        LX0702: 1

Experts

1.	Kong, Yi: 1 article (04/2015)
2.	Li, Zhiyu: 1 article (04/2015)
3.	Wang, Ying: 1 article (04/2015)
4.	Xie, Zhouling: 1 article (04/2015)
5.	Yang, Wei: 1 article (04/2015)

Related Diseases

1.	Thrombosis (Thrombus) 04/01/2015 - "LX0702, a novel snake venom peptide derivative, inhibits thrombus formation via affecting the binding of fibrinogen with GPIIb/IIIa."
2.	Hemorrhage 04/01/2015 - "These findings clearly demonstrate that LX0702 has anti-platelet/anti-thrombotic effects without increased bleeding risk. "

Related Drugs and Biologics

1.	Snake Venoms (Snake Venom)
2.	Peptides (Polypeptides)
3.	Fibrinogen (Factor I)